Synovus Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Sell |
1,307
-23
| -2% | -$5.03K | ﹤0.01% | 791 |
|
|
2025
Q1 | $298K | Hold |
1,330
| – | – | ﹤0.01% | 767 |
|
|
2024
Q4 | $436K | Sell |
1,330
-77
| -5% | -$25.2K | 0.01% | 676 |
|
|
2024
Q3 | $422K | Sell |
1,407
-65
| -4% | -$19.5K | ﹤0.01% | 723 |
|
|
2024
Q2 | $485K | Sell |
1,472
-71
| -5% | -$23.4K | 0.01% | 621 |
|
|
2024
Q1 | $611K | Buy |
+1,543
| New | +$611K | 0.01% | 579 |
|
|
2022
Q3 | – | Sell |
-1,521
| Closed | -$466K | – | 887 |
|
|
2022
Q2 | $466K | Buy |
1,521
+88
| +6% | +$27K | 0.01% | 600 |
|
|
2022
Q1 | $589K | Sell |
1,433
-62
| -4% | -$25.5K | 0.01% | 578 |
|
|
2021
Q4 | $695K | Buy |
1,495
+28
| +2% | +$13K | 0.01% | 547 |
|
|
2021
Q3 | $620K | Sell |
1,467
-658
| -31% | -$278K | 0.01% | 560 |
|
|
2021
Q2 | $763K | Buy |
+2,125
| New | +$763K | 0.01% | 503 |
|
|
2020
Q3 | – | Sell |
-55
| Closed | -$12K | – | 1467 |
|
|
2020
Q2 | $12K | Sell |
55
-733
| -93% | -$160K | ﹤0.01% | 1191 |
|
|
2020
Q1 | $120K | Buy |
788
+733
| +1,333% | +$112K | ﹤0.01% | 874 |
|
|
2019
Q4 | $8K | Buy |
55
+21
| +62% | +$3.06K | ﹤0.01% | 1252 |
|
|
2019
Q3 | $5K | Hold |
34
| – | – | ﹤0.01% | 1297 |
|
|
2019
Q2 | $4K | Hold |
34
| – | – | ﹤0.01% | 1265 |
|
|
2019
Q1 | $4K | Hold |
34
| – | – | ﹤0.01% | 1277 |
|
|
2018
Q4 | $3K | Hold |
34
| – | – | ﹤0.01% | 1287 |
|
|
2018
Q3 | $4K | Buy |
+34
| New | +$4K | ﹤0.01% | 1276 |
|
|
2015
Q2 | – | Sell |
-61
| Closed | -$4K | – | 1042 |
|
|
2015
Q1 | $4K | Buy |
61
+30
| +97% | +$1.97K | ﹤0.01% | 957 |
|
|
2014
Q4 | $2K | Hold |
31
| – | – | ﹤0.01% | 1005 |
|
|
2014
Q3 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 958 |
|